John McKune - 01 Mar 2024 Form 4/A Insider Report for Pulmonx Corp (LUNG)

Reporting relationship: INTERIM CFO
Issuer ticker: LUNG
Reported as of: 01 Mar 2024
Net transaction value: $0
SEC form: 4/A
Accepted by SEC: 07 Mar 2024, 19:57:55 UTC
Original report date: 05 Mar 2024
Prior SEC filing: 05 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ John McKune

Key filing fact

John McKune filed Form 4/A for Pulmonx Corp (LUNG) on 07 Mar 2024.

Key facts

This page summarizes John McKune's Form 4/A filing for Pulmonx Corp (LUNG).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Mar 2024, 19:57.

Change

Previous filing in this sequence was filed on 05 Dec 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LUNG transaction

Common Stock

Award

Transaction value: $0
Shares: +28,800
Change %: +61%
Price: $0.000000
Shares after: 76,210
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LUNG transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +14,400
Change %
Price: $0.000000
Shares after: 14,400
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,400
Exercise price: $9.30
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024.

Footnote F2

The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024.

SEC remarks

This amendment is being filed solely to correct the inadvertent typographical errors in the number of shares underlying the Employee Stock Option and Restricted Stock Units and the total securities owned after such transactions as reported in the original Form 4 filed with the SEC on March 5, 2024.